GSE98905The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma
Homo sapiens
10 Downloadable Samples
Affymetrix Human Genome U219 Array (hgu219)Submitter Supplied Information
Description
Double Hit Lymphoma (DHL) were treated with the BRD4 inhibitor 100 nM CPI203 for 6h
PubMed ID
Total Samples
10
Submitter’s Institution
Authors
Source Repository
Alternate Accession IDs
Samples
Show of 0 Total Samples
Filter
Add/Remove
Accession Code
Title
Specimen part
Cell line
Subject
Processing Information
Additional Metadata
Loading...
Some fields may be harmonized. Learn more